Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shanghai Junshi Biosciences Co., Ltd. has announced the composition of its board of directors, which includes key figures such as Mr. Xiong Jun as Chairman and Dr. Zou Jianjun as CEO. The company has also established four committees to enhance its governance structure, reflecting its strategic focus and commitment to bolstering corporate oversight.
For further insights into HK:1877 stock, check out TipRanks’ Stock Analysis page.